Braga N, Aymerich F X, Alonso J, Mongay-Ochoa N, Pareto D, Montalban X, Vidal-Jordana A, Sastre-Garriga J, Rovira À
From the Department of Neurology-Multiple Sclerosis Centre of Catalonia (Cemcat)(N.B., N.M.-O., X.M., A.V.-J., J.S.-G.), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Section of Neuroradiology, Department of Radiology (F.X.A., J.A., D.P., À.R.), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
AJNR Am J Neuroradiol. 2025 Apr 2;46(4):847-851. doi: 10.3174/ajnr.A8605.
Synthetic MRI (SyMRI) is a short-time acquisition sequence that generates different contrast-weighted images based on the measurement of tissue properties and provides quantitative volumetric, relaxation, and myelin maps. It has been used as an alternative to conventional MRI sequences in relapsing-remitting MS for detecting focal lesions and volumetric analysis. This study aimed to find an SyMRI variable associated with an Expanded Disability Status Scale (EDSS) ≥ 6 in progressive patients.
Twenty-four patients with progressive MS underwent SyMRI with a 2D axial QRAPMASTER pulse sequence. We analyzed volumetric parameters, global myelin fraction (MyCF), and quantitative values derived from maps of proton density, R1, R2, and myelin for the masks: normal-appearing white and gray matter, lesion, and corpus callosum. A test compared SyMRI variables between groups, followed by univariate binary logistic regression for significant ( < .05) or trending results ( < .09).
Patients were categorized into 2 groups (EDSS < 6 versus ≥ 6). Variables with significant differences between groups were: brain parenchymal fraction ( = .05), white matter fraction ( = .05), MyCF ( = .04), and corpus callosum volume ( = .04). In the binary logistic regression analysis, the best predictor of the EDSS category was MyCF, with a value of .08, and an OR of 0.59.
Our results confirm differences in volumetric parameters by EDSS by using a single MRI acquisition. Additionally, higher MyCF values were associated with lower disability, highlighting SyMRI and myelin quantification as potential tools for clinical practice.
合成磁共振成像(SyMRI)是一种短时间采集序列,可基于组织特性测量生成不同的对比加权图像,并提供定量的体积、弛豫和髓鞘图谱。在复发缓解型多发性硬化症中,它已被用作传统MRI序列的替代方法,用于检测局灶性病变和进行体积分析。本研究旨在寻找与进展型患者扩展残疾状态量表(EDSS)≥6相关的SyMRI变量。
24例进展型多发性硬化症患者接受了二维轴向QRAPMASTER脉冲序列的SyMRI检查。我们分析了体积参数、整体髓鞘分数(MyCF)以及从质子密度、R1、R2和髓鞘图谱得出的定量值,用于正常外观的白质和灰质、病变以及胼胝体的感兴趣区。采用检验比较两组之间的SyMRI变量,随后对显著(<0.05)或有趋势的结果(<0.09)进行单变量二元逻辑回归分析。
患者被分为两组(EDSS<6与≥6)。两组之间有显著差异的变量包括:脑实质分数(=0.05)、白质分数(=0.05)、MyCF(=0.04)和胼胝体体积(=0.04)。在二元逻辑回归分析中,EDSS分类的最佳预测指标是MyCF,P值为0.08,比值比为0.59。
我们的结果证实了通过单次MRI采集,EDSS在体积参数上存在差异。此外,较高的MyCF值与较低的残疾程度相关,突出了SyMRI和髓鞘定量作为临床实践潜在工具的作用。